Compare COCH & AGIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | COCH | AGIG |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | 47 | 2 |
| Industry | Blank Checks | Oil & Gas Production |
| Sector | Finance | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.1M | 49.4M |
| IPO Year | N/A | N/A |
| Metric | COCH | AGIG |
|---|---|---|
| Price | $0.64 | $1.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 117.1K | ★ 221.5K |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $1.01 |
| 52 Week High | $1.91 | $5.31 |
| Indicator | COCH | AGIG |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 45.91 |
| Support Level | $0.63 | $1.01 |
| Resistance Level | $0.73 | $1.68 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 15.98 | 60.87 |
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Abundia Global Impact Group Inc. is a technology solutions company operating in recycling, renewable energy, environmental change, fuels, and chemicals sectors, mainly focused on low-carbon energy solutions. The company uses waste plastics and biomass to produce crude or drop-in alternatives to fossil-derived energy, fuels, and chemicals through proprietary, licensed, and commercialized technologies, forming a complete process. It operates through its subsidiary and integrates feedstocks, technology, and off-take partners into a complete commercial chain. Its segments include Oil and Gas (O&G), which generates maximum revenue, and Renewables, which consists of its low-carbon fuels and renewable chemicals business.